Introduction
the p53 protein in absence of stress and exerts negative effect on DNA double strand break repair (Boersma et al., 2006; Akisik et al., 2011) . SNP at nucleotide 309 characterized as a change of T to G. T-to-G SNP in the promoter region of MDM2 leads to increased MDM2 expression by binding of the transcriptional activator to promoter of MDM2. MDM2 T309G interacts with p53 and mutations in p53 are present in approximately 50% of all cancers (Bond et al., 2004; Copson et al., 2006; Wilkening et al., 2007; Zhao et al., 2012) . Several studies have showed that there has been associated between MDM2 T309G and breast, colon cancer (Bond et al., 2006b) , lymphoma and soft tissue sarcomas (Bond et al., 2006a) .
In a previous study, we investigate the effect of MDM2 gene T309G polymorphism on development of lung cancer and gastric cancer in a Turkish population Yilmaz et al., 2017) . In the present study, we aimed to investigate the association between genetic polymorphisms of the MDM2 gene T309G polymorphism and breast cancer in Turkish population.
Materials and Methods

Study population and samples collection
Total 248 individuals consisted of 110 patients with breast cancer and 138 controls were investigated in this study. 
DNA isolation
Peripheral blood samples (2 ml) were obtained and collected into citrate-containing tubes from all subjects. The DNA was extracted from whole blood using the salting out procedure as soon as the samples reached the laboratory (Miller et al., 1988) .
MDM2 Genotyping
The MDM2 T309G polymorphism was analyzed using the polymerase chain reaction (PCR)-restriction fragment length polymorphism method. The following primers were used: Forward, 5'-CGC GGG AGT TCA GGG TAA AG-3' and reverse, 5'-CTG AGT CAA CCT GCC CAC TG-3' to amplify the MDM2 polymorphism. Amplification was performed using the following: 25 pmol each primer, 200 mM total dNTP, 1.5 mM MgCI 2 , 1µl PCR buffer and 2.5 U Taq DNA polymerase and 50-100 ng DNA in a total volume of 50 µl. The PCR program was initiated with 
Statistical Analysis
All statistical analyses were performed by using Statistical Package for Social Sciences Program-version 22.0 (SPSS inc., Chicago, IL, USA). Frequencies of characteristics and distributions of allele-genotype for this polymorphism between patients and controls were calculated with chi-square test (χ 2 ). Hardy-Weinberg equilibrium (HWE) in genotype distributions of both groups was also evaluated via a χ2 test. We detected in our study that frequencies of genotype for controls fixed HWE, whereas genotype frequencies for patient group were not consisted with HWE. Therefore, we used Cochran's and Mantel-Haenszel statistics for to calculate of odds ratio (OR). The crude OR in 95% confidence interval (CI) was calculated using Fisher's exact test. P values of <0.05 were considered statistically significant.
Results
A total of 248 Turkish women were studied (110 patients with breast cancer and 138 healthy controls) in current study. The main characteristics of study groups have been shown in Table 1 . No statistically significant difference was observed between cases and controls regarding the age (p=0.141). The family history of cancer, smoking habit and alcohol consumption frequencies were same in both groups (p>0.05). Frequencies of genotypes and OR values in both groups for MDM2 rs2279744 polymorphism were shown in table II. In statistical analysis using Chi-square (χ 2 ) test, we observed that there was a significant difference between case and control groups for distribution of MDM2 rs2279744 polymorphism (p<0.05). There was a significantly increased frequency of the TT genotype in control group (p=0.028; OR, 2.42; 95% CI, 1,09-5,37).
We also investigated the effect of MDM2 rs2279744 polymorphism on tumor grade and metastasis status. Regarding these factors there were no significant effects of MDM2 rs2279744 polymorphism as shown in =2,12). Any case-control study not reported that the interaction between MDM2 SNP309 was associated with evaluated breast cancer risk in smoker in the world. A family history of breast cancer seems to be the greatest risk factor for early onset breast cancer, and the risk is a function of the number of affected relatives, the degree of relationship, and the time of onset (Beral et al., 2004) . Our study, there was no statistically significant difference was observed between cases and controls regarding the family history of cancer (p=0,26, χ 2 =1,22).Similar to our study, in a study that has made Koh et al. (2011) there was no statistically significant difference between cases and controls regarding the family history of cancer (OR: 1,49, %95 CI: 0,55-4,03) (Koh et al., 2011) . But, Compbell et al., (2006) found that statistically significant difference between breast cancer cases and controls regarding the family history of cancer (OR: 0,99, %95 CI: 0,62-1,59) (Campbell et al., 2006) .
The activation of p53 protein over cellular stress such as DNA damage and oncogene activation leads to induction of cell cycle detention and the activation of apoptotic cell death, and may account for the role of this tumor suppressor protein in preventing the accumulation of genomic alterations and tumor development (Jin and Levine, 2001) . Somatic inactivating mutations of the p53 gene are found in over 50% of all human tumors (Lain and Lane, 2003) . MDM2 directly binds to p53 and acts as a crucial negative modulator for maintaining function of p53 through regulating its location, stability, and activity (Harris and Levine, 2005) . A subset of tumors overexpresses MDM2, which is associated with accelerated cancer progression (Freedman and Levine, 1999) and poor prognosis (Poyurovsky and Prives, 2006) . Therefore, inherently consisting functional polymorphisms of the p53 gene have also been investigated for possible association with human susceptibility to cancer. In our study, we investigated that stratification analyses between MDM2 SNP309 genotypes and breast cancer risk. We found a significant association between MDM2 SNP309 and breast cancer risk for TG and GG genotypes in Turkish population when individuals with TG and GG genotypes were compared individuals with TT genotype (TG genotype: OR:2,38, %95 CI: 1,27-4,47
Discussion
Early onset breast cancer is a multifactorial disease, and the genesis and progression of most breast cancers are influenced by both environmental and genetic factors (Beral et al., 2004) . Potentially modifiable factors associated with increased breast cancer risk include weight gain after the age of 18 and/or being overweight or obese for postmenopausal breast cancer, use of combined estrogen and progestin, physical inactivity, and alcohol (Table  II) . Similarly, Alshatwi et al., (2012) (Table III ). In the same way, Yadav et al., (2016) found no significant relationship their, but excluding metastasis (p=0, 04). This study provides basic information about the genotype frequency distributions of polymorphisms of rs2279744 in the MDM2 gene studied. The MDM2 polymorphisms in other studies conducted in Turkey has not been evaluated in terms of clinical parameters, which is very important to understand whether or how much impact associated polymorphisms of MDM2 SNP309 and breast cancer risk. The results of the present study, in conjunction with the results regarding MDM2 SNP309 gene polymorphisms in a Turkish population, provide a framework for further studies concerning the role of this gene as a susceptibility many diseases, including certain cancers
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